What's new

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 65, Status: Authorised

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 65, Status: Authorised

Apr 9, 2025 - 11:11
 0
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 65, Status: Authorised
Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Date of authorisation: 19/06/2015, Revision: 65, Status: Authorised
Read More

Tags:

Previous Article

Carl Friedrik x Williams Racing to launch an exclusive co-branded travel collection

Next Article

Inox Solar secures land to build 4.8GW solar cell and module assembly plant in I...

Related Posts

Human medicines European public assessment report (EPAR): Biktarvy, bictegravir,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/06/2018, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 27, 2025  0

Pharmacovigilance Risk Assessment Committee (PRAC): 7-10 April 2025, European Medicines Agency, Amsterdam, the Netherlands, from 7 April 2025 to 10 April 2025

Pharmacovigilance Risk Assessment Committee (PRAC): 7-1...

Apr 7, 2025  0

Herbal medicinal product: Eleutherococci radix, Eleutherococcus senticosus (Rupr. et Maxim.) Maxim., F: Assessment finalised

Herbal medicinal product: Eleutherococci radix, Eleuthe...

Feb 28, 2025  0